Cargando…

Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes: An analysis of baseline data from the ORIGIN trial

OBJECTIVE: A1C measurement has advantages over measures of plasma glucose. Few studies have evaluated the A1C–fasting plasma glucose (FPG) relationship and whether oral antidiabetes drugs (OADs) and ethnic or geographic variations affect the relationship. Baseline A1C and FPG data from the Outcome R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandran, Ambady, Riddle, Matthew C., Kabali, Conrad, Gerstein, Hertzel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308289/ https://www.ncbi.nlm.nih.gov/pubmed/22323416 http://dx.doi.org/10.2337/dc11-1918

Ejemplares similares

Response to Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922
por: Riddle, Matthew C., et al.
Publicado: (2013)

Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)
por: Lonn, Eva M., et al.
Publicado: (2013)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Efficacy of Primary Prevention Interventions When Fasting and Postglucose Dysglycemia Coexist: Analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2)
por: Ramachandran, Ambady, et al.
Publicado: (2010)

Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial
por: Franek, Edward, et al.
Publicado: (2022)

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial
por: Hanley, Anthony J., et al.
Publicado: (2010)

Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
por: Livadas, Sarantis, et al.
Publicado: (2022)

MON-636 The Relationship Between Glucose Control & Cognitive Function in People with Diabetes After a Lacunar Stroke
por: Cukierman-Yaffe, Tali, et al.
Publicado: (2020)

Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care 2016;39:1186–1201
por: Cefalu, William T., et al.
Publicado: (2017)

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2016)

LDL Cholesterol and Dysglycemia: an Intriguing Physiological Relationship
por: Merino, Jordi, et al.
Publicado: (2020)

Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity
por: Gupta, Jyotsna, et al.
Publicado: (2022)

Evaluation of an 8-Week Vegan Diet on Plasma Trimethylamine-N-Oxide and Postchallenge Glucose in Adults with Dysglycemia or Obesity
por: Argyridou, Stavroula, et al.
Publicado: (2021)

Dysglycemia and arrhythmias
por: Sun, Dong-Kun, et al.
Publicado: (2023)

Glucose Effectiveness in Obese Children: Relation to Degree of Obesity and Dysglycemia
por: Weiss, Ram, et al.
Publicado: (2015)

Are U‐shaped relationships between risk factors and outcomes artifactual?
por: Shah, Reema, et al.
Publicado: (2022)

The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years
por: Liu, Ting-ting, et al.
Publicado: (2017)

Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study
por: Ma, Haoming, et al.
Publicado: (2021)

Neuroanatomical Correlates of Dysglycemia in Young Children With Type 1 Diabetes
por: Marzelli, Matthew J., et al.
Publicado: (2014)

Dysglycemia in Pregnancy and Maternal/Fetal Outcomes
por: Silva, Corinne M., et al.
Publicado: (2021)

Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial
por: Cukierman-Yaffe, Tali, et al.
Publicado: (2009)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

Correction to: Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study
por: Ma, Haoming, et al.
Publicado: (2022)

Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
por: Doehner, Wolfram, et al.
Publicado: (2020)

Autoantibodies to Insulin and Dysglycemia in People With and Without Diabetes: An Underdiagnosed Association
por: Pavithran, Praveen Valiyaparambil, et al.
Publicado: (2016)

Which comes first in type 1 diabetes: Autoimmunity or dysglycemia?
por: Ikegami, Hiroshi
Publicado: (2023)

Observational assessments of the relationship of dietary and pharmacological treatment on continuous measures of dysglycemia over 24 hours in women with gestational diabetes
por: Dingena, Cassy F., et al.
Publicado: (2023)

Association between plasma betaine levels and dysglycemia in patients with coronary artery disease
por: Guo, Fei, et al.
Publicado: (2020)

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
por: Boye, Kristina S., et al.
Publicado: (2019)

Relationship Between Estimated Average Glucose (eAG) and Fasting Plasma Glucose in a Cohort of Pakistani Diabetic Subjects
por: Ram, Nanik, et al.
Publicado: (2021)

Prevention of diabetes: How far have we gone?
por: Ramachandran, Ambady, et al.
Publicado: (2014)

Dysglycemia in adults at risk for or living with non-insulin treated type 2 diabetes: Insights from continuous glucose monitoring
por: Barua, Souptik, et al.
Publicado: (2021)

An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia
por: Derosa, Giuseppe, et al.
Publicado: (2020)

Plasma Adiponectin Does Not Correlate With Insulin Resistance and Cardiometabolic Variables in Nondiabetic Asian Indian Teenagers
por: Snehalatha, Chamukuttan, et al.
Publicado: (2008)

Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes
por: Brambilla, Paolo, et al.
Publicado: (2011)

Plasma glucose in screening for diabetes and pre-diabetes: how much is too much? Analysis of fasting plasma glucose and oral glucose tolerance test in Sri Lankans
por: Katulanda, G. W., et al.
Publicado: (2019)

Dysglycemia and Arthroplasty Outcomes: A Review
por: Alkindy, Talal
Publicado: (2020)

Insulin as a Tool in Factitious Dysglycemia
por: Odhaib, Samih A, et al.
Publicado: (2021)

Plasma Carotenoids and Onset of Dysglycemia in an Elderly Population: Results of the Epidemiology of Vascular Ageing Study
por: Akbaraly, Tasnime N., et al.
Publicado: (2008)

Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence
por: Ali, Mohammed K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_csd6fq31224fndookam75037sj